Hagedorn H W, Schulz R, Friedrich A
Institute of Pharmacology, Toxicology and Pharmacy, University of Munich, Germany.
J Chromatogr. 1992 Jun 10;577(2):195-203. doi: 10.1016/0378-4347(92)80240-q.
The metabolic transformation of methandienone (I) in the horse was investigated. After administration of a commercial drug preparation to a female horse (0.5 mg/kg), urine samples were collected up to 96 h and processed without enzymic hydrolysis. Extraction was performed by a series of solid-liquid and liquid-liquid extractions, thus avoiding laborious purification techniques. For analysis by gas chromatography-mass spectrometry, the extracts were trimethylsilylated. Besides the parent compound I and its C-17 epimer II, three monohydroxylated metabolites were identified: 6 beta-hydroxymethandienone (III), its C-17 epimer (IV) and 16 beta-hydroxymethandienone (V). In addition, three isomers of 6 beta,16-dihydroxymethandienone (VIa-c) were discovered. Apparently, reduction of the delta 4 double bond of 16 beta-hydroxymethandienone (V) in the horse yields 16 beta,17 beta-dihydroxy-17 alpha-methyl-5 beta-androst-1-en-3-one (VII). Reduction of the isomers VIa-c results in the corresponding 6 beta,16,17-trihydroxy-17-methyl-5 beta-androst-1-en-3-ones (VIIIa-c). The data presented here suggest that screening for the isomers of VI and VIII, applying the selected-ion monitoring technique, will be the most successful way of proving methandienone administration to a horse.
对去甲雄三烯醇酮(I)在马体内的代谢转化进行了研究。给一匹母马投喂一种市售药物制剂(0.5毫克/千克)后,收集长达96小时的尿液样本,且不经过酶水解处理。通过一系列固液萃取和液液萃取进行提取,从而避免了繁琐的纯化技术。为了用气相色谱 - 质谱联用仪进行分析,提取物进行了三甲基硅烷化处理。除了母体化合物I及其C - 17差向异构体II外,还鉴定出了三种单羟基化代谢物:6β - 羟基去甲雄三烯醇酮(III)、其C - 17差向异构体(IV)和16β - 羟基去甲雄三烯醇酮(V)。此外,还发现了6β,16 - 二羟基去甲雄三烯醇酮(VIa - c)的三种异构体。显然,马体内16β - 羟基去甲雄三烯醇酮(V)的δ4双键还原会生成16β,17β - 二羟基 - 17α - 甲基 - 5β - 雄甾 - 1 - 烯 - 3 - 酮(VII)。异构体VIa - c的还原会生成相应的6β,16,17 - 三羟基 - 17 - 甲基 - 5β - 雄甾 - 1 - 烯 - 3 - 酮(VIIIa - c)。此处给出的数据表明,应用选择离子监测技术筛查VI和VIII的异构体,将是证明马摄入去甲雄三烯醇酮的最成功方法。